Core Insights - DuPont de Nemours, Inc. has a market capitalization of $18.8 billion and operates globally in technology-based materials and solutions, focusing on Healthcare & Water Technologies and Diversified Industrials [1][2] Financial Performance - DuPont's shares have decreased by 12.7% from their 52-week high of $52.66, but have increased by 12.2% over the past three months, outperforming the S&P 500 Index, which declined by 1.5% during the same period [3] - Year-to-date, DuPont's stock has gained 14.4%, while the S&P 500 has seen a marginal drop [6] - Over the past 52 weeks, DuPont's shares have surged by 43%, compared to the S&P 500's return of 20.8% [6] Recent Developments - On February 10, DuPont reported Q4 2025 results with adjusted EPS of $0.46, up from $0.39 the previous year, and operating EBITDA of $409 million [7] - For the full year 2025, net sales grew by 2% to $6.8 billion, operating EBITDA increased by 6% to $1.63 billion, and adjusted EPS rose by 16% to $1.68 [7] - The company provided optimistic guidance for 2026, projecting net sales between $7.08 billion and $7.14 billion, and adjusted EPS of $2.25 to $2.30 [7] Market Position - DuPont's stock has outperformed its rival International Flavors & Fragrances Inc. (IFF), which has gained only 8.1% year-to-date and decreased by 9.3% over the past 52 weeks [8] - Analysts maintain a consensus rating of "Strong Buy" for DuPont, with a mean price target of $55.73, indicating a potential upside of 21.2% from current levels [8]